GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...

Pre-treatment disease trajectories in severe asthma impact treatment-related outcomes, according to a study by Johannes ...

A Wisconsin family is suing Walgreens and OptumRx after a sudden inhaler price hike from $66 to $539 forced their son to ...

New research suggests that elevated circulating cAMP levels could serve as a potential biomarker for asthma. Read more.